CONSOLIDATED STATEMENTS OF CASH FLOWS - UNAUDITED - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Cash flows from operating activities
Net income (loss)	$ 10,837	$ (6,880)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Depreciation and amortization	276	195
Stock-based compensation expense	3,159	729
Bad debt expense	1,023	841
Noncash lease costs	0	230
Noncash amortization of debt discount	369	0
Noncash interest expense associated with convertible debt	243	710
Noncash change in fair value of derivatives	(36,264)	0
Other	15	44
Changes in operating assets and liabilities:
Accounts receivable	(675)	(674)
Prepaid expenses and other current assets	(2,222)	(600)
Accounts payable	173	(3)
Accrued expenses and other current liabilities	(2,141)	1,713
Deferred revenue	77	594
Net cash used in operating activities	(25,130)	(3,101)
Cash flows from investing activities
Additions of property, equipment, and software	(2,194)	(38)
Net cash used in investing activities	(2,194)	(38)
Cash flows from financing activities
Proceeds from exercise of stock options	158	223
Proceeds from convertible promissory notes	29,374	31,470
Proceeds from business combination placed in escrow and restricted	39,032	0
Trust proceeds received from recapitalization at closing	582	0
Repurchase of common stock and settlement of forward purchase agreements	(31,303)	0
Transaction costs associated with recapitalization	(10,761)	0
Payments on related party payables	(17)	(242)
Net cash provided by financing activities	27,065	31,451
Net (decrease) increase in cash, cash equivalents, and restricted cash	(259)	28,312
Cash, cash equivalents, and restricted cash, beginning of period	28,695	4,934
Cash, cash equivalents, and restricted cash, end of period	28,436	33,246
Supplemental disclosure of non-cash financing activities
Stockholder contribution for debt issuance costs	924	0
Repurchase of common stock in other accrued expenses	360	0
Conversion of promissory notes into common stock	33,024	0
Issuance of forward share purchase agreements	14,170	0
Issuance of private warrants	3,916	0
Issuance of sponsor shares subject to earnout conditions	6,867	0
Issuance of stockholder earn-out rights	$ 26,131	$ 0